Again with the MSB MSB MSB …. this is CYP …. it appears that it is you that can’t let things go ?
A USA FDA trial has now expanded globally but hey keep believing that won’t increase the initial estimates / costs ? I am not the only one on on here that has made reference to the costs of the USA FDA GVHD trial and the bank balance - without the exercising of the options I say the company will need a CR … you claim it won’t …. I say good luck with that … @Pledge and others on here have shared my opinion ….. some of us will be right and some will be wrong but regardless I plan to take half off the table here on the back of (hopefully) positive DFU results and let the remainder of my investment (free carry) ride whatever happens awaiting the outcome of the phase 3 osteoarthritis trial …. Enjoy your evening
CYP Price at posting:
18.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)